Braasch Biotech
Chemicals & Related Products · South Dakota, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
421 Rose Ave, Garretson, South Dakota, 5...Phone Number
(605) 376-8752Website
www.braaschbiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Braasch Biotech
Braasch Biotech LLC is a preclinical stage vaccine company focused on the discovery and development of innovative biopharmaceutical vaccine products for both human and animal healthcare markets. The company utilizes its Cross Platform Utilization of Vaccination (CPUV) technology to advance a diversified pipeline of second-generation somatostatin-based immunopharmaceutical vaccines. With successful proof-of-concept testing and a strong intellectual property portfolio, Braasch is poised for monetization and aims to deliver new treatment alternatives in the Growth Hormone and Insulin-like Growth Factor markets. Their platform technology presents significant opportunities for creating a wide range of new products in the healthcare sector.Explore more
Braasch Biotech Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Braasch Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Braasch Biotech
Check if Braasch Biotech has recently received funding, and reach out quickly before it becomes old news!
Check out if Braasch Biotech is spiking on competitors!
Funding: Get notified immidiatlly once Braasch Biotech has new funding data
Product Launch: Get notified when Braasch Biotech launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Braasch Biotech recently announced quarterly report
Click to see if Braasch Biotech had a recent Job posting/layoffs
Braasch Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Braasch Biotech as Masked Content
Find 2 more new buyers
Compare Similar Companies to Braasch Biotech
Compare insights from companies similar to Braasch Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Braasch Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Braasch Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Braasch Biotech.
Braasch Biotech Tech Stack
A closer look at the technologies used by Braasch Biotech
See more technologies
Braasch Biotech News & Media
Brazil Patent Allowance for Human Obesity Vaccines to Braasch Biotech
New Patent for Therapeutic Vaccine Treatment for Obesity in humans. GARRETSON, SD, US, February 24, 2021 /EINPresswire.com/ -- Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today …
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Braasch Biotech
Sign Up For FreeTo access detailed company insights
Braasch Biotech LLC is a preclinical stage vaccine company focused on the discovery and development of innovative biopharmaceutical vaccine products for both human and animal healthcare markets. The company utilizes its Cross Platform Utilization of Vaccination (CPUV) technology to advance a diversified pipeline of second-generation somatostatin-ba... Read More
